CMS Relationship With Manufacturers Has Improved, But Questions Remain
Executive Summary
The relationship between CMS and drug manufacturers is improving through earlier communication regarding coverage decisions and emphasis on common interests, according to CMS Director-Coverage Analysis Group Steven Phurrough